Published in Am J Gastroenterol on June 01, 1999
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut (2000) 2.17
Cancer in inflammatory bowel disease. World J Gastroenterol (2008) 2.12
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol (2008) 1.79
Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? World J Gastroenterol (2012) 1.63
Magnification endoscopy, high resolution endoscopy, and chromoscopy; towards a better optical diagnosis. Gut (2003) 1.53
Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol (2008) 1.25
Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol (2004) 1.25
Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res (2011) 1.21
Colon cancer screening and surveillance in inflammatory bowel disease. Clin Endosc (2014) 0.95
Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. J Gastroenterol (2012) 0.95
Colorectal cancer in inflammatory bowel disease. Gut Liver (2008) 0.94
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol (2015) 0.90
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis (2010) 0.90
Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol (2014) 0.88
Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol (2013) 0.88
Chemoprevention of colorectal cancer in ulcerative colitis. Int J Colorectal Dis (2003) 0.85
Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn's disease. Gastroenterol Rep (Oxf) (2014) 0.83
Ursodiol and colorectal cancer or dysplasia risk in primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis. Dig Dis Sci (2013) 0.82
Backwash ileitis and the risk of colon neoplasia in ulcerative colitis patients undergoing restorative proctocolectomy. Dig Dis Sci (2013) 0.82
Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis. EBioMedicine (2015) 0.81
Proctocolectomy for colon cancer associated with ulcerative colitis a few months after living donor liver transplantation for primary sclerosing cholangitis: report of a case. Surg Today (2009) 0.78
The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2013) 0.77
In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment. Dig Dis Sci (2011) 0.76
Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluation. J Gastrointest Oncol (2015) 0.76
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. J Crohns Colitis (2016) 0.76
Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. World J Gastroenterol (2014) 0.76
Dysplasia and colitis. Can J Gastroenterol (2009) 0.75
Inflammatory Bowel Disease Associated Colorectal Neoplasia. J Gastrointest Dig Syst (2012) 0.75
A review of the medical treatment of primary sclerosing cholangitis in the 21st century. Ther Adv Chronic Dis (2016) 0.75
Primary sclerosing cholangitis and the risk of colon neoplasia in patients with Crohn's colitis. Gastroenterol Rep (Oxf) (2015) 0.75
Suitability of surveillance colonoscopy for patients with ulcerative colitis to detect colorectal cancer: current guidelines miss some early-stage cases. Nagoya J Med Sci (2015) 0.75
Is ileal pouch-anal anastomosis after Whipple procedure doable? Tech Coloproctol (2016) 0.75
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intest Res (2017) 0.75
Inflammatory bowel disease: the problems of dysplasia and surveillance. Tech Coloproctol (2007) 0.75
miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling. Inflamm Bowel Dis (2017) 0.75
The role of liver biopsy in chronic hepatitis C. Hepatology (2001) 2.47
Celiac disease is highly prevalent in lymphocytic colitis. J Clin Gastroenterol (2001) 2.29
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21
Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol (1998) 2.13
The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer (2000) 2.12
Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation. Hepatology (1990) 2.06
Long-term results of percutaneous endopyelotomy in the treatment of children with failed open pyeloplasty. J Urol (1997) 2.02
Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol (1993) 1.70
The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis. Aliment Pharmacol Ther (2012) 1.52
Azathioprine therapy in chronic ulcerative colitis. J Clin Gastroenterol (1990) 1.46
Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. Am J Gastroenterol (1995) 1.46
The utility of the 13C-galactose breath test as a measure of liver function. Aliment Pharmacol Ther (2003) 1.43
Ultrasound-guided liver biopsy for parenchymal liver disease: an economic analysis. Dig Dis Sci (1998) 1.41
Chemical peeling as adjuvant therapy for facial neurotic excoriations. J Am Acad Dermatol (1994) 1.37
Can the need for a physician as part of the pediatric transport team be predicted? A prospective study. Crit Care Med (1992) 1.37
Seasonality in human reproduction: an update. Hum Reprod (1992) 1.37
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut (1997) 1.32
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant (2004) 1.30
Prevalence and incidence of inflammatory bowel disease in family members. Gastroenterology (1986) 1.26
When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology (1986) 1.23
Clostridium difficile culture-positive toxin-negative diarrhea. Am J Gastroenterol (1986) 1.20
Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology (1995) 1.20
The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology (1997) 1.19
A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis (2001) 1.19
Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology (2001) 1.14
Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther (1996) 1.13
The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Aliment Pharmacol Ther (2005) 1.13
Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol (1994) 1.11
Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther (2005) 1.10
Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol (1988) 1.09
Effects of homeopathic treatment in women with premenstrual syndrome: a pilot study. Br Homeopath J (2001) 1.09
Cryptosporidial enteritis in a homosexual male with an acquired immunodeficiency syndrome. Cleve Clin Q (1983) 1.08
Adenocarcinoma complicating Crohn's disease. Dis Colon Rectum (1993) 1.06
Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer (2003) 1.05
Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab (1987) 1.05
Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol (1999) 1.01
Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis. Genes Immun (2011) 1.01
Cigarette smoking in Crohn's disease. Am J Gastroenterol (1989) 1.01
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther (2002) 1.01
Effect of nutrient intake on premenstrual depression. Am J Obstet Gynecol (1989) 1.01
Neurological complications following liver transplantation. Ann Neurol (1992) 1.01
The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol (1997) 1.00
Lateralizing value of asymmetric tonic limb posturing observed in secondarily generalized tonic-clonic seizures. Epilepsia (2000) 0.98
The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology (1997) 0.97
Neurologic complications of liver transplantation. Transplantation (1988) 0.97
Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant (2004) 0.97
Ganglioneuromatosis of the colon and extensive glycogenic acanthosis in Cowden's disease. Dig Dis Sci (1986) 0.96
Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med (1995) 0.96
Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol (2013) 0.96
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin Cancer Res (2000) 0.95
Sarcoidosis of the eyelid skin. Can J Ophthalmol (1990) 0.94
Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma. J Natl Cancer Inst (1999) 0.94
C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med (1984) 0.94
Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program. Am J Gastroenterol (1998) 0.93
Periurethral injection for the treatment of urinary incontinence. Obstet Gynecol Surv (1998) 0.93
Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Bone Marrow Transplant (2005) 0.92
Clinical features and follow-up of surreptitious laxative users. Cleve Clin Q (1984) 0.91
Peer review revisited. Science (1975) 0.91
Supranormal renographic differential renal function in congenital hydronephrosis: fact, not artifact. J Urol (1999) 0.91
Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation. Bone Marrow Transplant (2009) 0.90
A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation. Bone Marrow Transplant (2002) 0.90
A phase II study of methylphenidate for depression in advanced cancer. Am J Hosp Palliat Care (2001) 0.89
Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol (1999) 0.89
Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS. Bone Marrow Transplant (2011) 0.89
Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy. Br J Obstet Gynaecol (1987) 0.89
Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies. Bone Marrow Transplant (2007) 0.89
Skeletal trauma preceding the development of plasma cell dyscrasia: eight case reports and review of the literature. Med Oncol (2003) 0.88
Prenatal diagnosis of hydronephrosis: impact on renal function and its recovery after pyeloplasty. J Urol (1999) 0.88
Cigarette smoking and ulcerative colitis: a case-control study. Mayo Clin Proc (1994) 0.87
Tumor cell resistance to topoisomerase II poisons: role for intracellular free calcium in the sensitization by inhibitors or calcium-calmodulin-dependent enzymes. Biochem Pharmacol (1998) 0.87
Bladder exstrophy associated with complete urethral duplication: a rare malformation with excellent prognosis. J Urol (2001) 0.87
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT. Bone Marrow Transplant (2010) 0.87
The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care (1995) 0.87
Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy. Climacteric (2009) 0.86
Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steril (1995) 0.86
The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis. Aliment Pharmacol Ther (2012) 0.86
Lateralizing value and semiology of ictal limb posturing and version in temporal lobe and extratemporal epilepsy. Epilepsia (1997) 0.86
Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia. Bone Marrow Transplant (2007) 0.86
Ovulation induction and risk of endometrial cancer: a pilot study. Eur J Obstet Gynecol Reprod Biol (2001) 0.85
Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia. Bone Marrow Transplant (2011) 0.85
Collagenous pouchitis. Dig Liver Dis (2006) 0.85
Endometriosis presenting as an inguinal hernia. Am J Obstet Gynecol (1983) 0.84
Recurrent acute pancreatitis and intussusception complicating an intraluminal duodenal diverticulum. Gastroenterology (1981) 0.84
A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy. J Hepatol (2001) 0.84
Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies. Br J Haematol (2006) 0.84
Risk of extraesophageal malignancy in patients with adenocarcinoma arising in Barrett's esophagus. Am J Gastroenterol (1995) 0.84
Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation. Bone Marrow Transplant (2011) 0.83
Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study. Bone Marrow Transplant (2012) 0.83
A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma. Bone Marrow Transplant (2008) 0.83
Prevalence of colonic neoplasia in patients with Barrett's esophagus. Am J Gastroenterol (1993) 0.83
Pulmonary lymphangiomyomatosis. Chest (1984) 0.83
Autologous hematopoietic cell transplantation non-Hodgkin's lymphoma: 100 month follow-up. Bone Marrow Transplant (2002) 0.82
Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction? Bone Marrow Transplant (2004) 0.82